CTRI/2009/091/000964已完成3 期
Evaluation of efficacy and safety of naftopidil versus tamsulosin for the treatment of benign prostatic hyperplasia: a randomized, open - label, comparative, active controlled, multi-centre trial.
试验速览
- 阶段
- 3 期
- 状态
- 已完成
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Male patients aged between 50-80 years.
- •2.Patients with diagnosis of BPH.
- •3.Patients with IPSS total score of ≥8
- •4.Patient willing to give their informed consent
排除标准
- •1.Patients having history of allergy to Alpha1 - adrenoceptor antagonists.
- •2.Patients on treatment with antiandrogen drugs.
- •3.Patients on current therapy with any Alpha1 - adrenoceptor antagonist.
- •4.Patients taking any drug with anticholinergic activity.
- •5.Patients with significant history of orthostatic hypotension.
- •6.Patients with concomitant neurological diseases, known or suspected neurogenic bladder dysfunction.
- •7.Patients with carcinoma of the prostate or bladder previous surgery for BPH or bladder neck obstruction.
- •8.Patients with history of recurrent UTI or Concomitant active UTI.
- •9.Patients who have serious mental illness.
- •10.Patient who have serious disorder with respect to cerebral blood vessels.
- •11.Patients who are taking drugs, which have phosphodiesterese 5 inhibitory action
研究者
相似试验
已完成
不适用
Efficacy of the escalating dose of naftopidil for patients with benign prostatic enlargement complicated by overactive bladderBenign prostatic hyperplasiaJPRN-UMIN000020031Department of Urology Nagoya University Graduate School of Medicine150
已完成
2 期
Evaluating the effects of intravenous immunoglobulin (IVIG) in COVID-19 patientsIRCT20151227025726N20Shahid Beheshti University of Medical Sciences80
进行中（未招募）
不适用
intravenous immunoglobulin for the treatment of infections in patients with post solid organ transplantation hypogammaglobulinemiainfections in patients with post solid organ transplantation IgG hypogammaglobulinemiaMedDRA version: 15.0Level: LLTClassification code 10054427Term: HypogammaglobulinemiaSystem Organ Class: 10021428 - Immune system disordersEUCTR2012-001327-12-ESFundacion para la Investigación Biomédica del Hospital Gregorio Marañón
已完成
3 期
A clinical trial to study the effects of two drugs, naftifine and terbinafine in patients with dermatophytosis.CTRI/2009/091/000679Sun Pharmaceutical Industries Ltd.
进行中（未招募）
1 期
Assessment of nemolizumab in subjects with prurigo nodularisPrurigo nodularisEUCTR2017-001715-36-FRGALDERMA R&D, SNC100